These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 596167)

  • 41. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.
    Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC
    Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Microbiological contamination of enclosed air spaces. Origin, methods for studying].
    Isoard P; Calop J; Contamin C
    J Chir (Paris); 1982; 119(8-9):503-12. PubMed ID: 6754752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hygienic evaluation of the air as a source of microbial drug contamination].
    Dubinskii RA; Strelkov VN
    Gig Sanit; 1981 Feb; (2):76-7. PubMed ID: 6452309
    [No Abstract]   [Full Text] [Related]  

  • 44. [Atmospheric control in the pharmaceutical industry].
    Alexis J; Brouwers L; Calay-Mertens MT; Capel-Boute C; Cooper TG; De Maeyer-Cleempoel S; Houtart B; Ledger I; Lhoest W; Rappe A
    J Pharm Belg; 1975; 30(4):325-30. PubMed ID: 1107511
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of methods for detection of particulate matter in large-volume perenterals.
    Blanchard J; Thompson CM; Schwartz JA
    Am J Hosp Pharm; 1976 Feb; 33(2):144-50. PubMed ID: 1258874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Some aspects on the use of the Biotest RCS Air Sampler in unidirectional air flow testing.
    Ljungqvist B; Reinmüller B
    J Parenter Sci Technol; 1991; 45(4):177-80. PubMed ID: 1770410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluating aseptic technique of pharmacy personnel.
    Brier KL
    Am J Hosp Pharm; 1983 Mar; 40(3):400-3. PubMed ID: 6342376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new laminar flow biological contamination control hood.
    Marsh RC
    Bull Parenter Drug Assoc; 1970; 24(3):134-47. PubMed ID: 5422902
    [No Abstract]   [Full Text] [Related]  

  • 49. [Devices for use in pharmaceutical filling machines to reduce the presence of particles glass in glass ampules].
    Lencioni E; Franchi G; Reghini A; Pezzuoli G
    Boll Chim Farm; 1983 Jan; 122(1):10-9. PubMed ID: 6882528
    [No Abstract]   [Full Text] [Related]  

  • 50. Absolute or sterilizing grade filtration--what is required?
    Kawamura K; Jornitz MW; Meltzer TH
    PDA J Pharm Sci Technol; 2000; 54(6):485-92. PubMed ID: 11107841
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of drug production technology on the transition of cesium-137 to liquid drug form].
    Antonova VA; Seditskaia ZL
    Gig Sanit; 1989 Jul; (7):87-8. PubMed ID: 2529188
    [No Abstract]   [Full Text] [Related]  

  • 52. [Cleaning of machines for pharmaceutical production: microbiological investigation to establish validation procedures].
    Anastasio P; Carazzone M; Genova R; Malesani L; Molinari ML
    Boll Chim Farm; 1987 Mar; 126(3):116-20. PubMed ID: 3689577
    [No Abstract]   [Full Text] [Related]  

  • 53. [On the particle size in prescription preparation of eye ointments].
    Bormann G
    Pharm Prax; 1967; 12():334-7. PubMed ID: 5616580
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of high-efficiency particulate air filtration on mortality and fungal infection: a rebuttal.
    Bodey GP; Freireich EJ
    J Infect Dis; 2006 Dec; 194(11):1621-2; author reply 1622-3. PubMed ID: 17083053
    [No Abstract]   [Full Text] [Related]  

  • 55. [A statistical model for evaluation of air microbes in pharmaceutical production areas. Group for the study of microbiology of the AFI].
    Denti M; Aina P; Viganò C; Cojazzi ME; Fabbroni A
    Boll Chim Farm; 1995 Feb; 134(2):96-102. PubMed ID: 7598838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Particulate matter possible in type B vertical-flow hoods.
    Power LA; Pech JG
    Am J Hosp Pharm; 1982 Apr; 39(4):574. PubMed ID: 7081230
    [No Abstract]   [Full Text] [Related]  

  • 57. [The microbiologic quality of an oral preparation as the result of proper formulation and technological design].
    Anastasio P; Carazzone M; Pongiluppi S
    Boll Chim Farm; 1988; 127(11-12):245-8. PubMed ID: 3254250
    [No Abstract]   [Full Text] [Related]  

  • 58. Biological indicators in the pharmaceutical and the medical device industry.
    Pflug IJ; Odlaug TE
    J Parenter Sci Technol; 1986; 40(5):242-8. PubMed ID: 3540254
    [No Abstract]   [Full Text] [Related]  

  • 59. Microbiological control in the manufacture of sterile pharmaceutical products.
    Bühlmann X
    Pharm Acta Helv; 1971 Jul; 46(7):385-409. PubMed ID: 4934853
    [No Abstract]   [Full Text] [Related]  

  • 60. Validation and routine operation of a sterile dry powder filling facility.
    Prout G
    J Parenter Sci Technol; 1982; 36(5):199-204. PubMed ID: 6927748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.